So is this it in a nut shell:
- we have bought a CAR-T for $12m
- That CAR-T has been greenlighted to go straight to a registrational trial
- Because of its orphan status that trial is way quicker and easier
- The trial will cost $20m
If I am correct in my understanding then those are all the good things about this deal. Indeed, it seems a good deal period. The bad aspect is the CAP Raise. Totally unnecessary and certainly should not have been done at a discount. Could have been funded from existing cash.
I don't agree that we should have bought this company given they hold other tech we don't need and the license price was about as cheap as it gets. I would hope there is still more announcements to come before we trade again. I hope they just consolidate now and dual list on the nasdaq to get it over with. I think that would help lift the SP.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-85
-
- There are more pages in this discussion • 422 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 0.056 |
5 | 286362 | 0.055 |
12 | 3517552 | 0.054 |
17 | 2756044 | 0.053 |
23 | 2021898 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 1368288 | 7 |
0.058 | 2564048 | 15 |
0.059 | 3137099 | 10 |
0.060 | 2176188 | 16 |
0.061 | 1460386 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online